期刊文献+

初发Graves病患者^(131)I治疗前后IL-23/Th17轴相关因子水平的变化及意义 被引量:10

Effects of ^(131)I treatment on the IL-23/Th17 axis relevant factor levels in graves disease patients
下载PDF
导出
摘要 目的:通过检测初发Graves病(GD)患者131I治疗前后不同阶段IL-23/Th17轴相关因子水平,探讨IL-23/Th17轴在GD发病机制中的作用。方法:收集初发GD组和正常对照组各30例。初发GD组分治疗前(T0)及131I治疗后1个月(T1)、3个月(T3)三组。应用ELISA法检测各组血清IL-17A、IL-17F、IL-22、IL-23水平,电化学发光法检测游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、促甲状腺素(TSH)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TgAb)、促甲状腺素受体抗体(TRAb)水平。结果:T0组血清IL-17A、IL-17F、IL-23水平明显高于正常对照组(P<0.01);IL-17A、IL-17F、IL-23水平在T0、T1、T3组逐渐下降,仍高于正常对照组(P<0.01);IL-22治疗前后无统计学差异(P>0.05)。采用双变量相关性分析得出IL-17A、IL-17F、IL-23与FT3、FT4呈正相关(rs>0.626,P=0.000),与TSH呈负相关(rs<-0.600,P=0.000)。结论:IL-23/Th17轴相关因子在初发GD中高表达,IL-23/Th17轴可能在GD的发病中起到重要作用。另外,放射性131I可能通过影响IL-23/Th17轴起到治疗GD的作用。 Objective:To explore the role of IL-23/Th17 axis in the pathogenesis of Graves disease(GD),by detecting the IL-23/Th17 axis relevant factor levels before and after 131I treatment with GD patients(who were newly diagnosed).Methods: The study subjects were divided into GD group and normal group.30 subjects were enrolled in each group.The GD group was divided into three groups such as before 131I treatment(T0),one month(T1) and three months(T3) after the 131I treatment.The levels of serum IL-17A,IL-17F,IL-22 and IL-23 were measured by ELISA.FT3,FT4,TSH,TPOAb,TgAb and TRAb levels were determined by electrochemiluminescence.Results: The levels of serum IL-17A,IL-17F and IL-23 in the GD group were significantly higher than the normal group(P0.01);the levels of serum IL-17A,IL-17F and IL-23 in T0,T1,T3 decreased gradually,but still higher than in normal group(P0.01);there was no significant difference in the level of IL-22 before and after 131I treatment(P0.05).Bivariate correlations revealed that IL-17A,IL-17F,IL-23 were strongly associated positively with FT3,FT4(rs0.626,P=0.000),but correlated negatively with TSH(rs-0.600,P=0.000).Conclusion: IL-23/Th17 axis factors are highly expressed in the GD group.IL-23/Th17 axis may play an important role in the pathogenesis of GD.In addition,radioactive 131I may also work on GD via IL-23/Th17 axis.
机构地区 山东大学
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第7期733-735,754,共4页 Chinese Journal of Immunology
关键词 GRAVES病 131I治疗前后 IL-23/Th17轴 发病机制 Graves disease Before and after 131I treatment IL-23/Th17axis Pathogenesis
  • 相关文献

参考文献5

二级参考文献118

  • 1阎胜利.Graves病与环境因素[J].山东医药,2005,45(7):63-64. 被引量:3
  • 2Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004; 22:789-815.
  • 3Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. JAllergy Clin Immunol 2003; 111:450-463; quiz 464.
  • 4Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003; 3:405-412.
  • 5Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003; 3:405-412.
  • 6Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
  • 7Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbetal and a novel cytokine receptor subunit, IL-23R. J Immunol 2002; 168:5699-5708.
  • 8Uhlig HH, McKenzie BS, Hue S, et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006; 25:309-318.
  • 9Hue S, Ahem P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006; 203:2473-2483.
  • 10Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. JExp Med2003; 198:1951-1957.

共引文献883

同被引文献117

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部